StockNews.com Begins Coverage on Calithera Biosciences (NASDAQ:CALA)

Equities researchers at StockNews.com assumed coverage on shares of Calithera Biosciences (NASDAQ:CALA) in a research note issued to investors on Tuesday. The brokerage set a “hold” rating on the biotechnology company’s stock.

Calithera Biosciences Price Performance

Calithera Biosciences stock opened at $0.00 on Tuesday. Calithera Biosciences has a 12 month low of $0.00 and a 12 month high of $0.12. The company has a fifty day moving average price of $0.01 and a two-hundred day moving average price of $0.01.

About Calithera Biosciences

Calithera Biosciences, Inc operates under a plan of liquidation that was approved in January 2023. Previously, the company was engaged in the clinical stage precision oncology biopharmaceutical business. Calithera Biosciences, Inc was incorporated in 2010 and is headquartered in South San Francisco, California.